Humana Inc.

NYQ: HUM
Live Quote

📈 ZcoreAI Score

Our AI model analyzes Humana Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get HUM Z-Score →

About Humana Inc.

Healthcare Healthcare Plans
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

📊 Fundamental Analysis

Humana Inc. demonstrates a profit margin of 0.9%, which is below the sector average, suggesting competitive pressure.

The company recently reported 11.3% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is 7.0%, which suggests room for improvement in capital utilization.

At a current price of $192.15, HUM currently trades near the bottom of its 52-week range (19%), indicating potential value or weakness (Range: $163.11 - $315.35).

💰 Valuation Insight

HUM is valued broadly in line with the sector at a PE of 19.53. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
⚠️ Revenue Growth Moderate
🔴 Return on Equity Weak
Beta (Risk) Low Volatility

Key Financials

Market Cap
$23.17B
Trailing P/E
19.53
Forward P/E
12.61
Beta (5Y)
0.45
52W High
$315.35
52W Low
$163.11
Avg Volume
2.20M
Day High
Day Low
Get HUM Z-Score on Dashboard 🚀